Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Eli Lilly and Co
Recent news which mentions Eli Lilly and Co
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Jim Cramer supports megacaps for the long term, even as Wall Street continues to sell
July 18, 2024
Tags
Investment strategy
Stock Picks
Amazon/com Inc
From
CNBC.com News
CNBC Daily Open: Rising geopolitical risk
July 18, 2024
Tags
Obesity
Pharmaceuticals
Oil and Gas
From
CNBC.com News
CNBC Daily Open: Rising geopolitical risk
July 17, 2024
Tags
Meta Platforms Inc
Airlines
Inflation
From
CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
July 17, 2024
Tags
Pharmaceuticals
Zealand Pharma A/S
Business
From
CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
July 16, 2024
Tags
Healthy Returns
UnitedHealth Group Inc
Health care industry
From
CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
July 11, 2024
Tags
Health care industry
Eli Lilly and Co
Healthy Returns
From
CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
July 11, 2024
Tags
Health care industry
Eli Lilly and Co
Biotech and Pharmaceuticals
From
CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
July 10, 2024
Tags
Mad Money
Eli Lilly and Co
Novo Nordisk A/S
From
CNBC.com News
Jim Cramer reviews 8 companies that could top $1 trillion in market cap
July 10, 2024
Tags
NVIDIA Corp
Markets
Amazon/com Inc
From
CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
July 10, 2024
Tags
CVS Health Corp
UnitedHealth Group Inc
Health care industry
From
CNBC.com News
Companies besides tech can reach megacap status, Jim Cramer says
July 08, 2024
Tags
Investment Strategy
Business
Stock markets
From
CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
July 06, 2024
Tags
Investment strategy
Finance
Markets
From
CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
July 03, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Eli Lilly and Co
From
CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
July 03, 2024
Tags
Eli Lilly and Co
Asia Markets
Daily Open
From
CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
July 02, 2024
Tags
Technology
World Markets
Daily Open
From
CNBC.com News
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
July 02, 2024
Tags
Health & Science
Breaking News: Business
Business News
From
CNBC.com News
Watch now: ETF Edge on reshoring trends, weight loss drugs and more
July 01, 2024
Tags
ETF Edge
Markets
Amgen Inc
From
CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
Tags
Health & Science
Science
Altimmune Inc
From
CNBC.com News
Jim Cramer's top picks for pet-centric stocks
June 25, 2024
Tags
Mad Money
Eli Lilly and Co
Investment strategy
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
June 25, 2024
Tags
Asia: Top News and Analysis
Asia News
Eli Lilly and Co
From
CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
June 24, 2024
Tags
Business
Pharmaceuticals
Biotechnology
From
CNBC.com News
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
June 21, 2024
Tags
Biotech and Pharmaceuticals
Eli Lilly and Co
Health care industry
From
CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
June 21, 2024
Tags
Breaking News: Markets
Eli Lilly and Co
Europe Markets
From
CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
June 18, 2024
Tags
Eli Lilly and Co
Health care industry
Healthy Returns
From
CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
June 17, 2024
Tags
Business News
Health & Science
Biotechnology
From
CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
June 11, 2024
Tags
Investment Strategy
Business
stocks
From
CNBC.com News
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
June 10, 2024
Tags
Business
Pharmaceuticals
Science
From
CNBC.com News
Jim Cramer's week ahead: Fed meeting and CPI report
June 07, 2024
Tickers
RH
Tags
Oracle Corp
Signet Jewelers Ltd
Apple Inc
From
CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
Tags
Science
Healthy Returns
Health & Science
From
CNBC.com News
Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI
June 06, 2024
Tags
Breaking News: Technology
Pharmaceuticals
Alphabet Inc
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.